2016 - Fellow of American Physical Society (APS) Citation For broad contributions to the interface of high energy theory and cosmology
His main research concerns Internal medicine, Colorectal cancer, Cancer research, Cancer and Genetics. The various areas that Daniel C. Chung examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology. His Oncology research integrates issues from Germline mutation, Carcinoid syndrome, Pathology, Late presentation and Natural history.
In his works, he undertakes multidisciplinary study on Colorectal cancer and Microsatellite instability. His studies in Cancer research integrate themes in fields like Regulation of gene expression and Loss of heterozygosity. His Cancer research is multidisciplinary, incorporating elements of Genetic counseling, Genetic testing and Hereditary diffuse gastric cancer.
His primary areas of investigation include Internal medicine, Colorectal cancer, Cancer research, Oncology and Pathology. His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology. His Colorectal cancer research is multidisciplinary, incorporating elements of Bevacizumab, Surgery and Genetic testing.
Daniel C. Chung works mostly in the field of Cancer research, limiting it down to topics relating to Loss of heterozygosity and, in certain cases, Tumor suppressor gene, as a part of the same area of interest. His research on Oncology frequently connects to adjacent areas such as Germline mutation. His work in Lynch syndrome addresses subjects such as MLH1, which are connected to disciplines such as MSH6.
Daniel C. Chung mainly focuses on Internal medicine, Colorectal cancer, RPE65, Oncology and Ophthalmology. His research on Internal medicine often connects related areas such as Gastroenterology. His study in the field of Lynch syndrome also crosses realms of Microsatellite instability.
His RPE65 research incorporates themes from Disease and Mutation. Daniel C. Chung focuses mostly in the field of Ophthalmology, narrowing it down to topics relating to Phase i ii and, in certain cases, Genetic enhancement. His Genetics study which covers Natural history that intersects with Gene.
Colorectal cancer, Internal medicine, Oncology, Cancer and Lynch syndrome are his primary areas of study. His study in Colorectal cancer is interdisciplinary in nature, drawing from both Risk assessment, Cancer research, DNA methylation, Genome instability and Genetic testing. His work carried out in the field of Genetic testing brings together such families of science as Genetic counseling, Early onset and Pathology.
The concepts of his Internal medicine study are interwoven with issues in RPE65 and Pediatrics. As part of his studies on Oncology, Daniel C. Chung often connects relevant areas like Retinal. His work on Cetuximab as part of his general Cancer study is frequently connected to Cost effectiveness, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda.
Nature Medicine (2004)
Gastroenteropancreatic neuroendocrine tumours.
Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen.
Lancet Oncology (2008)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic;Aleksandar D. Kostic;Eunyoung Chun;Lauren Robertson;Jonathan N. Glickman.
Cell Host & Microbe (2013)
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Monica M. Bertagnolli;Craig J. Eagle;Ann G. Zauber;Mark Redston.
The New England Journal of Medicine (2006)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell;Jean Bennett;Jennifer A. Wellman;Daniel C. Chung.
The Lancet (2017)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire;Albert M. Maguire;Katherine A. High;Katherine A. High;Alberto Auricchio;J. Fraser Wright;J. Fraser Wright.
The Lancet (2009)
The Chromosomal Instability Pathway in Colon Cancer
Maria S. Pino;Daniel C. Chung.
Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands
Choh Hao Li;David Chung.
Proceedings of the National Academy of Sciences of the United States of America (1976)
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
Rebecca C. Fitzgerald;Richard H Hardwick;David George Huntsman;Fátima Carneiro.
Journal of Medical Genetics (2010)
Regulation of Vascular Endothelial Growth Factor by the Wnt and K-ras Pathways in Colonic Neoplasia
Xiaobo Zhang;John P. Gaspard;Daniel C. Chung.
Cancer Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: